These 21 genes were then measured in estrogen receptor (ER)-positive node-negative patients (NSABP B-20) and showed a highly significant ability to predict disease recurrence, with the RT-PCR assay being the strongest predictor in multivariate analysis.
← all excerpts
26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on preclinical and translational research.
1
—
—